Sumatriptan (as succinate) 4mg/0.5mL, 6mg/0.5mL; for SC inj. Imitrex Injection is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as either prefilled syringe and/or ...

Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and ...

Teva and Antares Pharma announced the launch of Sumatriptan Succinate Injection, the generic version of GlaxoSmithKline's Imitrex Injection. Imitrex Injection is indicated in adults for the acute ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...

Compared with triptan nonresponders, patients with migraine who report a response to at least 1 triptan have a higher likelihood of responding to treatment with erenumab, according to real-world data ...

Please provide your email address to receive an email when new articles are posted on . A retrospective claims analysis included more than 184,000 individuals with migraine who used at least one ...

Imitrex (sumatriptan) is a prescription drug that’s used to treat migraine with or without an aura. It’s not known whether Imitrex may be safe to use while pregnant or breastfeeding. If you can become ...

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

Tosymra (sumatriptan) is a prescription drug used to treat migraine. The drug comes as a nasal spray. You usually use a single dose, which may be repeated two more times in a 24-hour period if needed.

Please provide your email address to receive an email when new articles are posted on . Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ...